Metataxonomic Analysis and Fatty Acid Profiling of Feces from Children Undergoing Hematopoietic Stem Cell Transplantation

Read full text
Authors: Claudio Alba, Laura Palomino, Beatriz Vergara, Marta Velasco Rodríguez-Belvís, Alberto Aragón, M Di Campli Zaghlul, Rubén Jurado, Carmen Martin‐Fernández, Julio A. Vázquez-Gómez, Marta Gonzalez-Vicent, Blanca Molina-Angulo, Paula Sánchez-Llorente
+4 more Paloma García-Hernández, Juan Miguel Rodríguez, Rosa Ana Muñoz-Codoceo, Carmen Herranz
Cited by: 1
References: 61

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is a medical procedure to treat hematologic malignancies and restore bone marrow function. However, this approach may lead to graft-versus-host disease (GvHD), a major cause of mortality and morbidity after allogeneic HSCT. Some studies have suggested the involvement of gut microbiota in the development and prognosis of GvHD. In this context, the main objective of this study was to compare the fecal microbiome composition and short-chain profile of pediatric patients who underwent successful HSCT, developed GvHD or died. The bacterial composition was analyzed using 16S rRNA gene sequencing, while short-chain fatty acids (SCFAs) were quantified by gas chromatography. Fecal samples at engraftment were mainly characterized by a loss of bacterial diversity, a depletion of sequences belonging to the genus Blautia and significantly lower concentrations of fecal butyrate and acetate compared with those obtained before HSCT and 100 days after HSCT. Our findings confirm that children experiencing GvHD after HSCT have distinct gut microbiota and SCFA profiles, which might contribute to developing new microbiota-targeted strategies for GvHD prevention during HSCT procedures.

Fields of Study & Subjects

Gut microbiota and health Neutropenia and Cancer Infections Hematopoietic Stem Cell Transplantation

Publication details

Journal / source
International Journal of Molecular Sciences
Publisher
MDPI AG
Volume
27
Issue
5
Pages
2331–2331
Publication date
2 March 2026
Language
EN